GAL and obesity due to melanocortin 4 receptor deficiency: In the future, more understanding of the physiological effects of GAL and SPX with three GALRs could lead to the development of new therapeutic strategies such as neuroendocrine-based obesity elimination and reproductive abnormalities using GAL and SPX.